Compare, Analyse SHASUN PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   MYLAN
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
MYLAN
Dec-18
SHASUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs943,503-   
Low Rs461,928-   
Sales per share (Unadj.) Rs214.21,611.8-  
Earnings per share (Unadj.) Rs5.343.8-  
Cash flow per share (Unadj.) Rs15.8345.6-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.31,743.7-  
Shares outstanding (eoy) m56.62514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.7 19.4%   
Avg P/E ratio x13.162.0 21.1%  
P/CF ratio (eoy) x4.47.9 56.2%  
Price / Book Value ratio x1.31.6 84.1%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9581,397,110 0.3%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM23,693.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM643.4-  
INCOME DATA
Net Sales Rs m12,127829,286 1.5%  
Other income Rs m2290-   
Total revenues Rs m12,356829,286 1.5%   
Gross profit Rs m1,009214,588 0.5%  
Depreciation Rs m594155,275 0.4%   
Interest Rs m41539,886 1.0%   
Profit before tax Rs m23019,428 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73-3,091 2.4%   
Profit after tax Rs m30222,519 1.3%  
Gross profit margin %8.325.9 32.2%  
Effective tax rate %-31.7-15.9 199.0%   
Net profit margin %2.52.7 91.7%  
BALANCE SHEET DATA
Current assets Rs m6,884463,072 1.5%   
Current liabilities Rs m8,456337,631 2.5%   
Net working cap to sales %-13.015.1 -85.7%  
Current ratio x0.81.4 59.4%  
Inventory Days Days6284 73.7%  
Debtors Days Days10893 115.3%  
Net fixed assets Rs m4,970160,868 3.1%   
Share capital Rs m113442 25.7%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,020897,136 0.3%   
Long term debt Rs m1,817968,297 0.2%   
Total assets Rs m13,3472,406,467 0.6%  
Interest coverage x1.61.5 104.5%   
Debt to equity ratio x0.61.1 55.8%  
Sales to assets ratio x0.90.3 263.7%   
Return on assets %5.42.6 207.2%  
Return on equity %10.02.5 398.5%  
Return on capital %13.33.2 419.0%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m398172,326 0.2%  
From Investments Rs m-1,635-89,073 1.8%  
From Financial Activity Rs m1,309-80,279 -1.6%  
Net Cashflow Rs m711,428 5.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.59 Rs / USD

Compare SHASUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: VENUS REMEDIES  STRIDES PHARMA SCIENCE  LUPIN  SUVEN LIFE SCIENCES  DR. DATSONS LABS  



Today's Market

SGX Nifty Down 34 Points; Indicates Negative Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:05 am, it was trading down by 34 points, or 0.2% lower at 14,675 levels.

Related Views On News

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS